JAMA Health Forum – Health Policy, Health Care Reform, Health Affairs

Research

Changes in US Hospital Financial Performance During the COVID-19 Public Health Emergency
Risha Gidwani, DrPH; et al.

Original Investigation
open access
Risha Gidwani, DrPH; et al.
Government vs Industry Spending on Phased Clinical Development of Approved Drugs
Edward W. Zhou, PharmD; et al.

Original Investigation
open access
Edward W. Zhou, PharmD; et al.

Invited Commentary
Neighborhood-Level Racial Residential Segregation, Socioeconomic Factors, and Life Expectancy
Sadiya S. Khan, MD, MSc; et al.

Research Letter
open access
Sadiya S. Khan, MD, MSc; et al.

Opinion

State Flexibility in Emergency Medicaid to Care for Uninsured Noncitizens
Jin K. Park, AB; et al.

Viewpoint
open access
Jin K. Park, AB; et al.
Drug Development—Social and Private Returns
Richard G. Frank, PhD

Invited Commentary
open access
Richard G. Frank, PhD
The Real Question the FDA Is Asking Its Advisory Committees
Genevieve P. Kanter, PhD

Invited Commentary
open access has multimedia
Genevieve P. Kanter, PhD

JAMA Forum

Health Care Issues in the Early Stages of the Presidential 2024 Election
Larry Levitt, MPP

JAMA Forum
open access
Larry Levitt, MPP
Understanding the US Health Care Industry as a Commercial Determinant of Health
Sandro Galea, MD, DrPH; et al.

JAMA Forum
open access
Sandro Galea, MD, DrPH; et al.
What Artificial Intelligence Means for Health Care
David M. Cutler, PhD

JAMA Forum
open access
David M. Cutler, PhD